Clinical Trial Update: Nebulized Dexmedetomidine Versus Neostigmine/Atropine in Postdural Puncture Headache [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nebulized dexmedetomidine to neostigmine/atropine for postdural puncture headache has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postdural Puncture Headache

Drugs mentioned

• Dexmedetomidine (nebulized) (dexmedetomidine)
• neostigmine/atropine (neostigmine)

Snippet

Sponsor: Assiut University | Conditions: Postdural Puncture Headache | Phase 3 | Status: COMPLETED